EGFR and breast cancer: Overexpression of RAC1 correlates with poor prognosis in breast cancer cells27, and the pharmacologic reduction or knockdown of V-ATPase activity significantly reduce migration of invasive tumor cells in vitro preventing activation of EGFR and RAC116.